Biomet Inc. announced the closure of the previously announced acquisition of the worldwide trauma business of DePuy Orthopedics Inc. With its closure, Biomet acquired DePuy Trauma’s operations in the United States, United Kingdom, Australia, New Zealand and Japan, as well as manufacturing operations in Switzerland, according to a company press release.
Biomet assumed responsibility for business operations on June 16. Within the next 6 months, DePuy Orthopedics will continue to close in remaining countries on a staggered basis. Until operations are fully transitioned to Biomet, affiliates of DePuy Orthopedics will serve as Biomet’s interim distributor.
“We take another step forward in our strategy to provide our surgeon and hospital customers with innovative products of the highest quality, and excellent service, on a global basis,” Jeffrey R. Binder, president and chief executive officer of Biomet Inc., stated in the release. “Trauma is one of the fastest growing market segments in orthopedics and at the core of orthopedic care. I would like to extend a warm welcome to our new team members, ad to surgeon and hospital customers around the world. All of us at Biomet look forward to working with you to fulfill our commitment to helping our customers improve the lives of their patients.”
Biomet also announced the end of their preliminary net sales results for the fourth quarter and fiscal year on May 31. Preliminary net sales for Biomet’s fourth quarter increased 3% compared to net sales reported in 2011 for a total of $739.5 million and 4% for the year for a total of $2.838 billion.
“As we exit fiscal year 2012 with a strong finish to our consolidated sales results and welcome the addition of our new trauma team members, we look forward with much enthusiasm to the possibilities in fiscal year 2013,” Binder stated.